Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center — Nashville, Tennessee

Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center has participated in 1 clinical trials.

Therapeutic areas: GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia.

Sponsors: Neovii Biotech.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center?

Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center conducted?

Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center has 1 clinical trials on record. Their work covers GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia.

Is Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center accredited by Crixeo Health?

Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.